BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 29565695)

  • 1. Long-term outcome of internal limiting membrane peeling with and without foveal sparing in myopic foveoschisis.
    Elwan MM; Abd Elghafar AE; Hagras SM; Abou Samra WA; Saleh SM
    Eur J Ophthalmol; 2019 Jan; 29(1):69-74. PubMed ID: 29565695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of non-fovea-sparing ILM peeling for symptomatic myopic foveoschisis with and without macular hole.
    Al-Badawi AH; Abdelhakim MASE; Macky TA; Mortada HA
    Br J Ophthalmol; 2019 Feb; 103(2):257-263. PubMed ID: 29712637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fovea-sparing internal limiting membrane peeling versus complete internal limiting membrane peeling for myopic traction maculopathy.
    Iwasaki M; Miyamoto H; Okushiba U; Imaizumi H
    Jpn J Ophthalmol; 2020 Jan; 64(1):13-21. PubMed ID: 31686266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LONG-TERM OUTCOMES OF 23-GAUGE PARS PLANA VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING AND GAS TAMPONADE FOR MYOPIC TRACTION MACULOPATHY: A Prospective Study.
    Figueroa MS; Ruiz-Moreno JM; Gonzalez del Valle F; Govetto A; de la Vega C; Plascencia RN; Contreras I; Medina JL
    Retina; 2015 Sep; 35(9):1836-43. PubMed ID: 25946689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic effects of pars plana vitrectomy combined with internal limiting membrane peeling on high myopic foveoschisis].
    Ying J; Li J; Xu GZ; Yu SP
    Zhonghua Yan Ke Za Zhi; 2020 Dec; 56(12):928-932. PubMed ID: 33342119
    [No Abstract]   [Full Text] [Related]  

  • 6. [Vitrectomy without internal limiting membrane peeling associated with gas tamponade for treatment of foveoschisis in pathologic myopia].
    Zhang YP; Xue AQ; Wang YQ; Yan WT; Song ZM
    Zhonghua Yan Ke Za Zhi; 2011 Jun; 47(6):497-503. PubMed ID: 21914263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING AND AIR TAMPONADE FOR MYOPIC FOVEOSCHISIS.
    Rizzo S; Giansanti F; Finocchio L; Caporossi T; Barca F; Bacherini D; Cocci G; Vannucchi M; Tartaro R; Virgili G
    Retina; 2019 Nov; 39(11):2125-2131. PubMed ID: 30015762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitrectomy and internal limiting membrane peeling with perfluoropropane tamponade or balanced saline solution for myopic foveoschisis.
    Zheng B; Chen Y; Chen Y; Zhao Z; Zhang Z; Zheng J; You Y; Wang Q; Shen L
    Retina; 2011 Apr; 31(4):692-701. PubMed ID: 21836401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fovea sparing internal limiting membrane peeling using multiple parafoveal curvilinear peels for myopic foveoschisis: technique and outcome.
    Jin H; Zhang Q; Zhao P
    BMC Ophthalmol; 2016 Oct; 16(1):180. PubMed ID: 27756275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of Foveal Architecture during Vitrectomy for Myopic Retinoschisis Identified by Intraoperative Optical Coherence Tomography.
    Itoh Y; Inoue M; Kato Y; Koto T; Hirakata A
    Ophthalmologica; 2019; 242(2):87-97. PubMed ID: 31203278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical outcomes of centripetal non-fovea-sparing internal limiting membrane peeling for myopic foveoschisis with and without foveal detachment: a follow-up of at least 3 years.
    Peng KL; Kung YH; Hsu CM; Chang SP; Tseng PL; Wu TT
    Br J Ophthalmol; 2020 Sep; 104(9):1266-1270. PubMed ID: 31831505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors correlated with postoperative visual acuity after vitrectomy and internal limiting membrane peeling for myopic foveoschisis.
    Kumagai K; Furukawa M; Ogino N; Larson E
    Retina; 2010 Jun; 30(6):874-80. PubMed ID: 20094010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitrectomy with or without internal limiting membrane peeling for each stage of myopic traction maculopathy.
    Taniuchi S; Hirakata A; Itoh Y; Hirota K; Inoue M
    Retina; 2013; 33(10):2018-25. PubMed ID: 23975004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitrectomy with or without internal limiting membrane peeling for myopic foveoschisis.
    Gui J; Ai L; Huang T
    BMC Ophthalmol; 2020 Mar; 20(1):83. PubMed ID: 32131776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitrectomy and internal limiting membrane peeling without gas tamponade for myopic foveoschisis.
    Lim SJ; Kwon YH; Kim SH; You YS; Kwon OW
    Graefes Arch Clin Exp Ophthalmol; 2012 Nov; 250(11):1573-7. PubMed ID: 22411130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCLERAL IMBRICATION COMBINED WITH PARS PLANA VITRECTOMY WITHOUT INTERNAL LIMITING MEMBRANE PEELING FOR MYOPIC SCHISIS.
    Baba T; Tanaka S; Nizawa T; Oshitari T; Yamamoto S
    Retina; 2016 Oct; 36(10):1927-34. PubMed ID: 27031526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitrectomy and internal limiting membrane peeling with and without gas tamponade for myopic foveoschisis.
    Kim KS; Lee SB; Lee WK
    Am J Ophthalmol; 2012 Feb; 153(2):320-326.e1. PubMed ID: 21982957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoschisis: A Predictive Factor in Vitrectomy for Lamellar Macular Holes in Highly Myopic Eyes.
    Tao J; Wu H; Chen H; Li G; Chen Y; Mao J; Shen L
    Ophthalmologica; 2019; 242(4):208-213. PubMed ID: 31315117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of microscope-integrated intraoperative optical coherence tomography-guided center-sparing internal limiting membrane peeling for myopic traction maculopathy: a novel technique.
    Kumar A; Ravani R; Mehta A; Simakurthy S; Dhull C
    Int Ophthalmol; 2018 Aug; 38(4):1689-1696. PubMed ID: 28676991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphologic and functional outcomes of different optical coherence tomography patterns of myopic foveoschisis after vitrectomy and inner limiting membrane peeling.
    Sborgia G; Boscia F; Niro A; Giancipoli E; D'Amico Ricci G; Sborgia A; Sborgia L; Recchimurzo N; Romano MR; Addabbo G; Alessio G
    Eye (Lond); 2019 Nov; 33(11):1768-1775. PubMed ID: 31209260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.